Two events in recent years especially signaled that robots were coming into their own in the space: Stryker spent $1.7 billion for Mako Surgical in order to sell robotic systems to aid knee and hip replacement surgeries, and Medtronic acquired Mazor Robotics for $1.7 billion so that it could expand into the robot-assisted spine surgery space.
Now all of the other big ortho device companies have either launched or are preparing to launch their own robots.
“Even if not necessarily proven to be better medicine, you can’t afford not to have an answer to robotics,” SVB Leerink analyst Richard Newitter recently told Medical Design & Outsourcing. “There’s a strategy now where having a robot is better than not having a robot.”
You may also like:
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!